Results 71 to 80 of about 19,432 (181)

Multilesional cutaneous leishmaniasis [PDF]

open access: yesCanadian Medical Association Journal, 2016
A 27-year-old healthy woman presented to the medical centre with a one-month history of widespread skin lesions with slow clinical progression. The lesions appeared on her thighs, shins, lower abdomen and left arm three weeks after she had travelled to an area endemic for Leishmania major ...
Yuval, Ramot, Abraham, Zlotogorski
openaire   +2 more sources

Recombinant LPG3 Protein From Leishmania chagasi as an Antigen for the Diagnosis of Canine Visceral Leishmaniasis

open access: yesTropical Medicine &International Health, Volume 31, Issue 8, Page 1057-1065, August 2026.
ABSTRACT Visceral leishmaniasis (VL) is a human neglected tropical disease in which dogs participate as reservoirs of the etiological agent Leishmania chagasi. The identification of infected dogs is important to the control of VL, and recombinant proteins are strong antigen candidates for canine visceral leishmaniasis (CVL) serodiagnosis. In this work,
Thaís Viana Fialho Martins   +12 more
wiley   +1 more source

Probing 5‐Nitroimidazole‐Triazole Hybrids as Potential Anti‐Kinetoplastid Agents: Synthesis and In Vitro Efficacy

open access: yesChemMedChem, Volume 21, Issue 13, 14 July 2026.
A series of 5‐nitroimidazole‐1,2,3‐triazole hybrids was synthesised and evaluated for antitrypanosomatid activity to assess their potential as treatments against leishmaniasis and trypanosomiasis. No notable in vitro activity against Leishmania was detected.
Liandi Ferreira   +4 more
wiley   +1 more source

Synthesis, Electrochemistry, In Vitro Antiprotozoal Efficacy and Mechanistic Study of Novel ‘Ferrantoin’ and Related Derivatives

open access: yesApplied Organometallic Chemistry, Volume 40, Issue 7, July 2026.
1,2‐Disubstituted ferrocene analogues bearing hydantoin or rhodanine synthons were synthesised and assessed for antitrypanosomatid activity. An antileishmanial early lead, analogue 23, acting through ROS generation and hence oxidative stress, was uncovered.
Maryna Saayman   +7 more
wiley   +1 more source

Striking Bone Marrow Plasmacytosis Resulting From Visceral Leishmaniasis

open access: yes
American Journal of Hematology, Volume 101, Issue 8, Page 2007-2008, August 2026.
Vishakha Sovani   +2 more
wiley   +1 more source

Rapid and Successful Treatment of Interstitial Granulomatous Dermatitis With Tofacitinib: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Interstitial Granulomatous Dermatitis (IGD) is a rare skin condition characterized by granulomatous inflammation. Despite various treatment options, the rarity of this condition makes management challenging. This report highlights the potential of Janus kinase inhibitors, specifically Tofacitinib, as an effective therapy for IGD.
Aida Farmani, Mina Saber
wiley   +1 more source

American Cutaneous Leishmaniasis

open access: yesArchives of Pathology & Laboratory Medicine, 2002
Abstract We present 3 cases of American cutaneous leishmaniasis occurring in soldiers of a unit of US Army Rangers who parachuted into the jungles of Panama. Shortly after returning to the United States, these 3 soldiers each developed a crusted, indurated papule, which slowly enlarged during the following 6 weeks.
M A J Michael, Royer, C O L Mark, Crowe
openaire   +2 more sources

Clinical and Diagnostic Considerations in Laryngeal Leishmaniasis: A Systematic Review

open access: yesOTO Open, Volume 10, Issue 3, July-September 2026.
Abstract Objective Laryngeal leishmaniasis is a rare, insidious manifestation of Leishmania infection with potential for life‐threatening complications. Awareness is critical for efficient and timely diagnosis. This systematic review of laryngeal leishmaniasis focuses on presentation, treatment, and the role of serological studies in the work up of ...
Joseph Celidonio   +7 more
wiley   +1 more source

Mini-Exon Genotyping of Leishmania Species in Khuzestan Province, Southwest Iran [PDF]

open access: yesIranian Journal of Parasitology, 2010
Background: Leishmaniasis is a protozoan disease cause by Leishmania genus. Anthroponotic and zoono­tic cutaneous leishmaniasis are endemic in Iran. The aim of this study was to identify the causative agent of cutaneous leishmaniasis by mini-exon gene in
J Saki   +7 more
doaj   +1 more source

A Declining Trend of 'Leishmaniasis' Based on Previous Data in Larstan, South of Iran 2007–2017

open access: yesAnnals of Global Health, 2019
Introduction: 'Cutaneous Leishmaniasis' is a unicellular of the Leishmania type, and 0.7 to 1.2 million people are annually infected by 'Cutaneous Leishmaniasis'. Larestan is one of the southern cities of Fars Province.
Ahmad Abolghazi   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy